Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
Cumpărați această carte electronică și primiți încă 1 GRATUIT!
Format EPUB ● Pagini 268 ● ISBN 9781315355900 ● Editor Kerry B. (Pfizer, Cambridge, Massachusetts, USA) Barker & Sr., Ralph B. (Boston University, Massachusetts, USA) D’Agostino ● Editura CRC Press ● Publicat 2016 ● Descărcabil 3 ori ● Valută EUR ● ID 5021283 ● Protecție împotriva copiilor Adobe DRM
Necesită un cititor de ebook capabil de DRM